Cytokinetics CYTK Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's deferred tax assets and other non-current assets?
- Cytokinetics (CYTK) reported deferred tax assets and other non-current assets of $18.47M in Q1 2026.
- How has Cytokinetics's deferred tax assets and other non-current assets changed year-over-year?
- Cytokinetics's deferred tax assets and other non-current assets increased by 45.5% year-over-year, from $12.7M to $18.47M.
- What is the long-term trend for Cytokinetics's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Cytokinetics's deferred tax assets and other non-current assets has grown at a 22.2% compound annual growth rate (CAGR), from $6.36M to $17.34M.